Publicação:
Estudo comparativo das complicações terapêuticas no Lúpus Eritematoso Sistêmico e nas glomerulopatias idiopáticas.

dc.contributor.authorBalbi, André Luis [UNESP]
dc.contributor.authorBarbosa, R. A.
dc.contributor.authorLima, M. C.
dc.contributor.authorAlmeida, D. B.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:20:18Z
dc.date.available2014-05-27T11:20:18Z
dc.date.issued2001-10-01
dc.description.abstractPURPOSE: To evaluate the therapeutic complications due to the use of immunosupressors in patients with nephropathy. METHODS: 76 patients who had used steroids and cyclophosphamide were retrospectively studied. The cases were divided into three groups: G1= 15 patients with Systemic Lupus Erythematosus without renal lesion; G2= 33 patients with lupus nephritis and G3= 28 patients with nephrotic syndrome owing to idiopathic glomerulopathy. RESULTS: There were no differences related to time of follow up (G1= 42.4 +/- 51, G2= 52.3 +/- 51, G3= 41.8 +/- 47.8 months), total used dosage of steroids (G1= 20, G2= 28, G3= 16 grams) and time of drug use (G1= 20, G2= 26, G3= 14.5 months). About cyclophosphamide use, there was no difference in the percentage of patients who used it (13% in G1, 51% in G2, 28% in G3), but the patients from G1 received lower total dosage than those from G2 (p<0.05). Cushingoid appearance, epigastric distress, psychiatric disorders, diabetes mellitus and ocular alterations occurred in all the three groups, with no statistically significant differences. The infections complications, those considered more severe clinically, were more frequent in G2 (G1= 6%, G2= 15%, G3= 0% - p<0.05), the same occurring with the deaths (7% in G1, 30% in G2, 0% in G3 - p<0.05). CONCLUSION: In patients with lupus nephritis there were more infections complications owing to prolonged immunosuppresion what may indicate a severity marker of this type of lesion.en
dc.format.extent296-301
dc.identifierhttp://dx.doi.org/10.1590/S0104-42302001000400031
dc.identifier.citationRevista da Associacao Medica Brasileira (1992), v. 47, n. 4, p. 296-301, 2001.
dc.identifier.doi10.1590/S0104-42302001000400031
dc.identifier.file2-s2.0-0035495938.pdf
dc.identifier.issn0104-4230
dc.identifier.lattes5697804493071661
dc.identifier.scieloS0104-42302001000400031
dc.identifier.scopus2-s2.0-0035495938
dc.identifier.urihttp://hdl.handle.net/11449/66591
dc.language.isopor
dc.relation.ispartofRevista da Associação Médica Brasileira (1992)
dc.relation.ispartofjcr0.736
dc.relation.ispartofsjr0,265
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectcorticosteroid
dc.subjectcyclophosphamide
dc.subjectimmunosuppressive agent
dc.subjectmethylprednisolone
dc.subjectprednisone
dc.subjectadult
dc.subjectcomparative study
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectlupus erythematosus nephritis
dc.subjectmale
dc.subjectnephrotic syndrome
dc.subjectretrospective study
dc.subjectsystemic lupus erythematosus
dc.subjectAdrenal Cortex Hormones
dc.subjectAdult
dc.subjectCyclophosphamide
dc.subjectFemale
dc.subjectFollow-Up Studies
dc.subjectHumans
dc.subjectImmunosuppressive Agents
dc.subjectLupus Erythematosus, Systemic
dc.subjectLupus Nephritis
dc.subjectMale
dc.subjectMethylprednisolone
dc.subjectNephrotic Syndrome
dc.subjectPrednisone
dc.subjectRetrospective Studies
dc.titleEstudo comparativo das complicações terapêuticas no Lúpus Eritematoso Sistêmico e nas glomerulopatias idiopáticas.pt
dc.title.alternativeA comparative study of therapeutic complications in Systemic Lupus Erythematosus and in idiopathic glomerulopathyen
dc.typeArtigo
dcterms.licensehttp://www.scielo.br/revistas/ramb/paboutj.htm
dspace.entity.typePublication
unesp.author.lattes5697804493071661[1]
unesp.author.orcid0000-0001-8366-5064[1]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentClínica Médica - FMBpt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
2-s2.0-0035495938.pdf
Tamanho:
89.02 KB
Formato:
Adobe Portable Document Format